The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has issued a warning to doctors regarding the misuse of obesity injections, such as Wegovy. This follows reports of individuals who are not obese experiencing adverse effects after using these medications for weight loss.
The MHRA emphasizes that these drugs are specifically designed for treating obesity and type 2 diabetes, and their safety and efficacy have only been established for these conditions. Health Secretary Wes Streeting has also voiced concerns, stating that these medications are “serious medicines” and should not be used for cosmetic purposes.
Doctors are advised to be vigilant and report any suspected cases of misuse. They should also ensure that patients are aware of the potential side effects of these medications and the importance of using them under medical supervision.
The MHRA emphasizes that these drugs are specifically designed for treating obesity and type 2 diabetes, and their safety and efficacy have only been established for these conditions. Health Secretary Wes Streeting has also voiced concerns, stating that these medications are “serious medicines” and should not be used for cosmetic purposes.
Doctors are advised to be vigilant and report any suspected cases of misuse. They should also ensure that patients are aware of the potential side effects of these medications and the importance of using them under medical supervision.